IVF with Preimplantation Genetic Testing (PGT)
Selection of the most appropriate embryo to be transferred to achieve a healthy live birth through in vitro fertilization treatments is one of the most important steps of assisted reproductive techniques. Achieving higher rates of healthy live births has become possible, especially by improving the selection criteria of the embryos to be transferred. With Preimplantation Genetic Tests (PGT), it is possible to identify embryos with healthy chromosome structures and prevent unnecessary embryo transfer that may result in implantation failure or miscarriage.
What is Preimplantation Genetic Testing (PGT)?
Preimplantation genetic testing (PGT) is a technique in which one or more cells are taken from an embryo (fertilized egg) for testing to have information about the genetic make-up of the embryo. It is done in a lab and used in conjunction with in vitro fertilization (IVF).
PGT is a new term in fertility medicine that replaces the more familiar terms of preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS), while serving the same functions as those screenings.
Preimplantation genetic testing has three types of screenings as listed below.
When to Consider Preimplantation Genetic Testing (PGT)?
Preimplantation genetic testing (PGT) screens embryos created through in vitro fertilization (IVF) for genetic and chromosome abnormalities before they are transferred to the uterus. For this reason, PGT increases the chance of IVF success and the probability of having a healthy baby.
Preimplantation genetic testing can be considered if;
Sex selection allows couples to prevent the transmission of sex-linked genetic disorders such as hemophilia, muscular dystrophy and fragile-X syndrome and to choose female or unaffected male embryos in order to prevent the risk of these genetic disorders in their children.
Patients may be interested in selecting the sex of their child to “balance” the number of girls or boys in their families.
Sex selection, also known as gender selection or family balancing, is the process of determining the gender (male or female) of each embryo created through in vitro fertilization (IVF).
The gender identification of embryos is done using preimplantation genetic testing (PGT), which involves taking a few cells from an embryo on the 3rd or 5th day after embryo creation, and determining the sex of the embryos through genetic analysis.
After testing, only the healthy embryos are implemented to woman’s uterus during an embryo transfer procedure.
How is the IVF treatment process with Preimplantation Genetic Testing (PGT)?
1 - Consultation
Your IVF journey begins with a consultation with one of our fertility experts, where we’ll discuss and assess your fertility status by reviewing your and your partner’s most recent blood tests and health reports and creating a customised plan for you.
2. Ovarian stimulation phase
3. Egg Retrieval
Our embryologists fertilise the collected eggs with your partner’s sperm. We use the ICSI method for the fertilisation procedure, injecting the selected sperm directly into the egg.
5. Preimplantation Genetic Testing (PGT)
After fertilisation, the embryos will be kept in a particular culture medium in the laboratory for five days. Following embryo creation, preimplantation genetic testing will be performed on 3rd or 5th day by taking a biopsy from each embryo.
6. Embryo Transfer
The healthy and highest-quality embryos are selected and transferred into the uterus at the end of the laboratory process. The number of embryos to be transferred is decided by our doctor with you, considering your age, general health, previous unsuccessful IVF attempts and the quality of the embryos. (If more than one embryo is transferred, the possibility of multiple pregnancies increases.) Based on the regulation in North Cyprus, we are allowed to transfer a maximum of three embryos at one transfer.
7. Embryo Freezing
After one or two healthy embryos are transferred into the uterus, the remaining embryos are frozen for future use on the same day of embryo transfer.
8. Pregnancy Test
In this way, your IVF cycle is completed. You will perform a pregnancy blood test after 12 days after the embryo transfer date and let us know the result.
Frequently Asked Questions About IVF With Preimplantation Genetic Testing (PGT)
Why to consider Preimplantation Genetic Testing (PGT)?
PGT helps identify any chromosomal abnormalities and increase the chances of a successful pregnancy while reducing the risk of miscarriage.
Patients who are interested in selecting the sex of their child for medical reasons can consider doing preimplantation genetic testing (PGT) in their IVF treatment.
What are the chances of determining the correct gender with PGT?
Sex is determined by the combination of X and Y sex chromosomes a baby receives from the egg and the sperm. Every egg has an X sex chromosome; a sperm can have either an X or a Y sex chromosome. If the sperm that fertilizes an egg has an X chromosome, the baby is a girl; if it has a Y chromosome, the baby will be a boy.
Intended Parents can determine the gender of the embryo through PGT-A (with FISH or NGS method) during their IVF journey. The gender identification process is almost 100% accurate with preimplantation genetic testing.
However, not all patients can produce healthy embryos of the desired gender because of factors related to age, egg supply, and sperm quality. So it is not possible to guarantee to reach the healthy desired gender after performing preimplantation genetic testing.
Does trophectoderm biopsy harm the embryo?
Today, highly advanced techniques are used for biopsy. Removing a few cells from the outer layer of the embryo due to biopsy does not affect the further development of the embryo. The results show that the survival rate of the embryo after the biopsy procedure is close to 100%. There is no evidence that trophectoderm biopsy can cause abnormalities in the embryo. Available data show no significant difference in congenital birth defects between IVF and (IVF with) PGT babies.
PGT procedure performed for genetic diagnosis may be harmful or harmless depending on at what stage of the embryo the biopsy is performed. If the PGT procedure is performed on the 3rd day of embryo development, an embryo which is still in the cleavage period may be damaged by this procedure and the implantation chance of these embryos may decrease by 30%.
On the 3rd day, a biopsy is performed by taking only 1-2 cells from the cells that form the embryo which contains 6-8 cells (blastomeres), on the 5th day, the biopsy is performed with cells taken from the trophectoderm tissue (the placenta) and not from the cells of the embryo that form the baby. Thus, the cells that will form the baby are not harmed with 5th day biopsy. On the 5th day, 5-6 cells are taken from the trophectoderm cells of the embryo showing blastocyst development and examined. This procedure allows to reach more reliable results as it makes working with a larger number of cells possible at one time and thus, increases pregnancy rates due to increased accuracy in diagnosis.
What is the Success Rate of IVF with Preimplantation Genetic Testing (PGT)?
The success rates can vary each year depending on several factors, as per below;
- Age of the woman
- The quality of eggs and sperm
- History of previous pregnancy
- Uterine or endometrial receptivity
- Lifestyle factors of the patient
The success rates of IVF with preimplantation genetic testing are higher than a regular IVF as PGT-A allows to identify the viable embryos for transfer. PGT-A helps to select embryos with the correct number of chromosomes, which can increase the chances of a successful pregnancy and reduce the risk of miscarriage.
For the success rates of IVF with Preimplantation Genetic Testing (PGT), you can check the success rates of IVF treatment, which can be found on our website in the link below.
What is the cost of IVF Treatment with Preimplantation Genetic Testing (PGT)?
For detailed information about the pricing, please visit our webpage https://cyprusivfhospital.com/pricing/